405 related items for PubMed ID: 12693764
1. Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.
Gan HC, Hyoon K, Fong KY.
Singapore Med J; 2002 Dec; 43(12):614-6. PubMed ID: 12693764
[Abstract] [Full Text] [Related]
2. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K, Yu Y, Tang Z, Liu Z, Li L.
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[Abstract] [Full Text] [Related]
3. Longterm followup of childhood lupus nephritis.
Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E.
J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
[Abstract] [Full Text] [Related]
4. [Lupus nephritis in children and adolescents: therapy, clinical course and prognosis].
Bogdanović R, Nikolić V, Ognjanović M, Dimitrijević J, Marković-Lipkovski J, Pasić S, Minić A, Stajić N.
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():6-12. PubMed ID: 12583307
[Abstract] [Full Text] [Related]
5. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[Abstract] [Full Text] [Related]
6. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[Abstract] [Full Text] [Related]
7. Treatment and renal outcome of lupus nephritis: single center experience.
Go KW, Teo SM.
Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
[Abstract] [Full Text] [Related]
8. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[Abstract] [Full Text] [Related]
9. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P.
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[Abstract] [Full Text] [Related]
10. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A, Sumboonnanonda A, Parichatikanond P, Supavekin S, Suntornpoch V, Vongjirad A.
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[Abstract] [Full Text] [Related]
11. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[Abstract] [Full Text] [Related]
12. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH, Millward CL, Olson JL, Amend WJ, Criswell LA.
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[Abstract] [Full Text] [Related]
13. Lupus nephritis: a 13-year experience.
Walker RJ, Bailey RR, Swainson CP, Lynn KL.
N Z Med J; 1986 Nov 26; 99(814):894-6. PubMed ID: 3468414
[Abstract] [Full Text] [Related]
14. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH.
J Rheumatol; 2002 Apr 26; 29(4):693-9. PubMed ID: 11950009
[Abstract] [Full Text] [Related]
15. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
Faurschou M, Starklint H, Halberg P, Jacobsen S.
J Rheumatol; 2006 Aug 26; 33(8):1563-9. PubMed ID: 16881113
[Abstract] [Full Text] [Related]
16. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA.
QJM; 2008 Apr 26; 101(4):313-6. PubMed ID: 18270227
[Abstract] [Full Text] [Related]
17. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
Sisó A, Ramos-Casals M, Bové A, Brito-Zerón P, Soria N, Muñoz S, Testi A, Plaza J, Sentís J, Coca A.
Lupus; 2008 Apr 26; 17(4):281-8. PubMed ID: 18413408
[Abstract] [Full Text] [Related]
18. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
Demircin G, Oner A, Erdoğan O, Delibaş A, Baysun S, Bülbül M, Bek K, Oksal A.
Ren Fail; 2008 Apr 26; 30(6):603-9. PubMed ID: 18661410
[Abstract] [Full Text] [Related]
19. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM.
J Rheumatol; 1994 Nov 26; 21(11):2052-7. PubMed ID: 7869309
[Abstract] [Full Text] [Related]
20. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
Arthritis Rheum; 2004 Dec 26; 50(12):3934-40. PubMed ID: 15593207
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
